Related Experiment Video
Updated: Jun 14, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
The ClinGen Syndromic Disorders Gene Curation Expert Panel: Assessing the clinical validity of 111 gene-disease
Eleanor C Broeren1, Vanessa N Gitau1, Alicia B Byrne1
1Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.
Insights
The ClinGen Syndromic Disorders Gene Curation Expert Panel (SD-GCEP) evaluated 111 gene-disease relationships for rare syndromic disorders. This work enhances clinical testing by assessing gene validity for complex genetic conditions.
Area of Science:
- Genetics
- Genomic Medicine
- Rare Diseases
Background:
- Gene curation efforts historically focused on specific organ systems or phenotypes.
- An unmet need existed for evaluating genes associated with syndromic disorders.
- The Clinical Genome Resource (ClinGen) established the Syndromic Disorders Gene Curation Expert Panel (SD-GCEP) to address this gap.
Purpose of the Study:
- To apply the ClinGen framework for evaluating the clinical validity of genes linked to rare syndromic disorders.
- To curate gene-disease relationships (GDRs) within the spectrum of syndromic conditions.
- To address the need for comprehensive gene assessment in syndromic genetic disorders.
Main Methods:
- Evaluated 111 gene-disease relationships (GDRs) involving 100 genes.
- Conducted 38 precurations to refine gene-disease classifications (lumping/splitting entities).
- Classified GDRs based on clinical validity: Definitive (78), Strong (9), Moderate (15), Limited (9).
Main Results:
- A total of 111 GDRs for 100 genes were curated.
- 78 GDRs were classified as Definitive, indicating strong evidence.
- The majority of diseases (79.2%) affected five or more organ systems, reflecting syndromic complexity.
Conclusions:
- The SD-GCEP successfully addresses a critical gap in gene curation for syndromic disorders.
- This work facilitates the inclusion of genes for syndromic conditions in clinical testing.
- The panel's efforts help keep pace with the rapid discovery of new genetic syndromes.
Purpose:
The Clinical Genome Resource (ClinGen) Gene Curation Expert Panels have historically focused on specific organ systems or phenotypes; thus, the ClinGen Syndromic Disorders Gene Curation Expert Panel (SD-GCEP) was formed to address an unmet need.
Methods:
The SD-GCEP applied ClinGen's framework to evaluate the clinical validity of genes associated with rare syndromic disorders. A total of 111 gene-disease relationships (GDRs) associated with 100 genes spanning the clinical spectrum of syndromic disorders were curated.
Results:
From April 2020 through March 2024, 38 precurations were performed on genes with multiple disease relationships and were reviewed to determine if the disorders were part of a spectrum or distinct entities. A total of 14 genes were lumped into a single disease entity, and 24 were split into separate entities, of which 11 were curated by the SD-GCEP. A full review of 111 GDRs for 100 genes followed, with 78 classified as Definitive, 9 as Strong, 15 as Moderate, and 9 as Limited, highlighting cases in which further data are needed. All diseases involved 2 or more organ systems, whereas the majority (88/111 GDRs, 79.2%) had 5 or more organ systems affected.
Conclusion:
The SD-GCEP addresses a critical gap in gene curation efforts, enabling inclusion of genes for syndromic disorders in clinical testing and contributing to keeping pace with the rapid discovery of new genetic syndromes.
More Related Videos
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Incomplete Dominance
Genomics

